✦ LIBER ✦

Double blind controlled randomized study on azathioprine efficacy in multiple sclerosis. Preliminary results

✍ Scribed by C. Milanese; L. La Mantia; A. Salmaggi; A. Campi; C. Bortolami; L. Tajoli; A. Nespolo; F. Corridori

Publisher: Springer Milan
Year: 1988
Tongue: English
Weight: 401 KB
Volume: 9
Category: Article
ISSN: 1590-1874
DOI: 10.1007/bf02334408

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A double blind study on azathioprine eff

A double blind study on azathioprine efficacy in multiple sclerosis: final report

✍ C. Milanese; L. Mantia; A. Salmaggi; M. Eoli 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 352 KB

Four year double-blind controlled study

Four year double-blind controlled study of levamisole in multiple sclerosis

✍ A. R. Massaro; R. P. Cioffi; A. Laudisio; D. Schiavino; M. Mariani 📂 Article 📅 1990 🏛 Springer Milan 🌐 English ⚖ 468 KB

Rituximab in patients with primary progr

Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial

✍ Kathleen Hawker; Paul O'Connor; Mark S. Freedman; Peter A. Calabresi; Jack Antel 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB 👁 2 views

## Abstract ## Objective Rituximab, a monoclonal antibody selectively depleting CD20+ B cells, has demonstrated efficacy in reducing disease activity in relapsing‐remitting multiple sclerosis (MS). We evaluated rituximab in adults with primary progressive MS (PPMS) through 96 weeks and safety thro

The effect of 4-aminopyridine on clinica

The effect of 4-aminopyridine on clinical signs in multiple sclerosis: A randomized, placebo-controlled, double-blind, cross-over study

✍ Harriët A. M. van Diemen; Dr. Chris H. Polman; Theo M. M. M. van Dongen; Arie C. 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 806 KB

Randomized, placebo-controlled, double-b

Randomized, placebo-controlled, double-blind study on clinical efficacy of ciclopiroxolamine 1% cream in facial seborrhoeic dermatitis

✍ P. Dupuy; C. Maurette; J.C. Amoric; O. Chosidow; THE STUDY INVESTIGATOR GROUP 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 353 KB

Magnetic resonance imaging results of th

Magnetic resonance imaging results of the PRISMS trial: A randomized, double-blind, placebo-controlled study of interferon-β1a in relapsing-remitting multiple sclerosis

✍ David K. B. Li; Donald W. Paty 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 2 views

The PRISMS (Prevention of Relapses and Disability by Interferon-␤1a Subcutaneously in Multiple Sclerosis) trial was a doubleblind, randomized, multicenter, phase III, placebo-controlled study of interferon-␤1a in 560 patients from 22 centers in 9 countries with clinically definite or laboratory-supp